1. Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease Hughes, Tasha; Iodice, Gail M.; Basu, Sanjib; Bines, Steven; Kaufman, Howard 2013 Presentations (Communicative Events) Cancer--ImmunotherapyMelanoma--TreatmentRenal cell carcinomaInterleukin-2ImmunotherapyOncologyMedicineImmunology
2. Inhibition of Caveolin-1 Restores Myeloid Cell Function in Human Glioblastoma Shimato, Shinji; Anderson, Lisa M.; Asslaber, Martin; Bruce, Jeffrey N.; Canoll, Peter D.; Anderson, David E.; Anderson, Richard C. E. 2013 Articles MonocytesMicrogliaCancer--ImmunotherapyGlioblastoma multiformeCytology
3. The role of surgery following incomplete response to high-dose IL-2 (HD IL-2) Hughes, Tasha; Iodice, Gail M.; Basu, Sanjib; Bines, Steven; Kaufman, Howard 2013 Presentations (Communicative Events) Excision (Surgery)Metastasis--SurgeryMetastasisMetastasis--TreatmentCancer--SurgeryCancer--ImmunotherapyInterleukin-2OncologyMedicineSurgeryImmunology